SUMMARY The genetic and immunologic abnormalities associated with the pathogenesis of moya-moya were assessed in 23, 13 children and 10 adults with angiographically diagnosed moya-moya. In HLA-A, -B, -C stereotyping, an association was found of AW24, BW46, and BW54 with relative risks of 3.83, 6*50, and 3-58 respectively. Natural T cell toxic autoantibody was detected by FACS analysis in sera from five out of 23 patients. Millipore filter assay for autoantibody against double-strinded DNA revealed higher than normal binding in sera from four out of 18 patients. Anti-vessel 
2-) 2- In patients with NTA or anti-ds DNA antibody or both, no correlation with the clinical findings was determined. Of the patients with such antibodies most were adults. Case 1, in which the clinical stage was "active" and the follow-up results were "poor", was remarkable in that both natural T cells antibody anti-ds DNA antibody were detected. Furthermore, this patient was typed as HLA-AW24 and -BW54 which overall showed a significant association with moya-moya.
Discussion
The major histocompatibility complex of man controls the human histocompatibility antigen expressed on leukocytes, that is, HLA and is inherited in a Mendelian fashion. Certain HLA types are reported to occur with high frequency in association with certain diseases. In our study of 18 patients, moyamoya was associated with HLA-AW24 (RR;3-83), BW46 (RR;6.50), and -BW54 (RR;3.58) ( genetic study is required. We have therefore attempted to investigate the relation between moya-moya and HLA haplotype. NTA was initially discovered in the New Zealand Black (NZB) mouse.8 These mice spontaneously develop a systemic autoimmune disease similar to that of human systemic lupus erythematosus.8 NTA also has been demonstrated in various human autoimmune diseases, such as systemic lupus erythematosis rheumatoid arthritis, progressive systemic sclerosis, myasthenia gravis, infectious mononucleosis.9'-" Previously, Okumura et al had obtained the same results in several examinations of autoimmune diseases. The autoantibody was detected in about 45% of the patients with systemic lupus erythematosis, 31 % with progressive systemic sclerosis, 23% with rheumatoid arthritis, and 86% with ulcerative colitis (table 3) . Moreover, in the NZB mouse, NTA is associated with the selective loss of the suppressor T cell function, followed by the development of autoimmune disease.'2 Therefore, the frequency of NTA in moya-moya, com- 
